Wacker acquires biopharmaceuticals site in Luxembourg

The Germany-based chemical group Wacker Chemie AG has acquired a Dutch site for manufacturing vaccines and microbial products from Luxembourg-based SynCo. The plants’ high output–thanks to two fermentation lines with capacities of 1,500 and 270 liters, will allow Wacker to enhance its biopharmaceutical pipeline (proteins). The facilities have already been inspected by EMA and FDA and employ 100 people.

(Source: Chemengoline)